All content for Future Science Group is the property of Taylor & Francis Group and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Exploring biomarker testing in bioanalytical Contract Research Organizations
First void urine: revolutionizing potential non-invasive biomarker collection
Future Science Group
14 minutes 7 seconds
1 week ago
First void urine: revolutionizing potential non-invasive biomarker collection
Join Tara Crawford-Parks, PhD, Director for Translational R&D and Product Enablement at DNA Genotek, to explore the potential of first void urine biomarkers in clinical diagnostics. Discover how this non-invasive sampling method is transforming HPV screening and opening new possibilities for early disease detection in oncology and infectious diseases. Learn about the science behind first void urine collection, its advantages over traditional sampling methods, and how innovative devices like the Colli-Pee™ are supporting more accessible healthcare for underserved populations worldwide.
Future Science Group
Exploring biomarker testing in bioanalytical Contract Research Organizations
